注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
華領醫藥是一家主要從事藥物開發業務的中國公司。該公司目前致力於開髮用於治療2型糖尿病的口服新藥Dorzagliatin或HMS5552。該公司主要在國內外市場開展業務。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Robert Taylor Nelsen | 60 | 2010 | Non-Executive Chairman |
Li Chen | 59 | 2010 | Founder, CEO & Executive Director |
Yiu Leung Cheung | 64 | 2023 | Independent Non-Executive Director |
Yiu Wa Tsui | 74 | 2018 | Independent Non-Executive Director |
James S. MacDonald | - | - | Member of Scientific Advisory Board |
Chien Cheng Lin | 53 | 2017 | Executive VP, Chief Strategy Officer & Executive Director |
Bennett M. Shapiro | 84 | - | Member of Scientific Advisory Board |
Catherine D. Strader | 69 | - | Member of Scientific Advisory Board |
William Robert Keller | 76 | 2018 | Independent Non-executive Director |
Fangxin Li | 32 | 2023 | Non-Executive Director |
Yi Zhang | 49 | 2018 | Senior VP of Pharma Development, Chief Medical Officer – China and Executive Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核